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Achieving natural product synthesis and diversity via catalytic 
networking ex wivo 
Charles A Roessner and A Ian Scott 
Recent studies on ex viva synthesis of natural products 
reveal that even complex multistep pathways can be 
successfully reconstructed. Genetic engineering of such 
reconstituted pathways has already been used to 
generate ‘unnatural’ natural products related to the 
original compound. In the future, it may be possible to 
use these approaches to make natural products that are 
currently inaccessible to conventional synthesis. 
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Natural product biosynthesis is a multi-step process often 
requiring as many as IS-20 gene products for the synthesis 
of a complex structure. Genetic engineering can function as 
a tool to increase production by removal of rigid branch 
points in the metabolic network, to overcome product inhi- 
bition, to identify intermediates by introduction of muta- 
tions or to synthesize new products by introduction of 
‘unnatural’ substrates or ‘foreign’ genes from different 
organisms (Fig 1). There are many examples in the litera- 
ture of whole-organism engineering, especially of pro- 
karyotes. Some of the best examples come from the 
engineering of Streptomyces pecies to define the polyketide 
biosynthetic pathways and generate novel polyketides 
Figure 1 
(reviewed in [ 11). Whole-organism engineering can, 
however, be hampered by the difficulty of engineering 
higher eukaryotic organisms, and various properties of cells. 
An inability to take up some unnatural substrates can limit 
the substrates it is possible to use, and the cytoplasmic 
environment constrains reaction conditions (pH, tempera- 
ture, etc.). Parts of the pathways may be shared by major 
metabolic pathways which, in v&o, compete for substrates 
but cannot be removed by mutation. Furthermore, using 
whole organisms does not reveal information about the 
mechanisms of the individual biosynthetic enzymes and 
requires no knowledge of the discrete intermediates bound 
or released from them. By contrast, in vitro multienzyme 
synthesis, while requiring the isolation and characterization 
of the full set of biosynthetic enzymes, is not beset by prob- 
lems of metabolic trafficking or growth conditions and has 
the added benefit of allowing one to identify and manipu- 
late the entire repertoire of biosynthetic intermediates and 
the enzymes that connect them to the natural product. 
The strategy chosen for in vitro syntheses must depend on 
the nature of the organism from which the metabolic route 
to the natural product is derived. Prokaryotes often have 
lengthy operons encoding the enzymes for up to 20 steps of 
a pathway. Thus selection of mutants and complementation 
studies with a genomic library provides a logical approach, 
yielding a small number of clones that can be subcloned and 
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expressed to produce the complete repertoire of biosyn- 
thetic enzymes. In eukaryotes, however, the biosynthetic 
genes are seldom (if ever) clustered, so a cDNA library must 
be constructed and probed with oligonucleotides or anti- 
bodies corresponding to the proteins of interest. As these are 
lengthy procedures, this is an area that is ripe for develop- 
ment, and the advent of differential display or ‘subtraction’ 
libraries [Z] is expected to have a profound impact. 
Whichever approach is used, the choice of expression vector 
is of paramount importance, and if the multienzyme 
synthesis requires expensive cofactors such as nucleoside 
triphosphates, NAD(P), S-adenosylmethionine (SAM) or 
3’-phosphoadenosine-S-phosphosulfate (PAPS), these can 
be regenerated [3] with a coupled enzyme system. 
Figure 2 
Multienzyme carbohydrate synthesis 
The concepts of reconstituting a pathway or mixing 
enzymes from interlinked pathways in a single reactor was 
made a reality by the early work of Whitesides and Wong 
(reviewed in [3]) who used commercially available enzymes 
involved in the metabolism of monosaccharides to synthe- 
size ribose-S-phosphate and ribulose-1,5-bisphosphate from 
glucose (Fig. Za) [4]. A similar concept was more recently 
employed to convert sucrose to the versatile substrate dihy- 
droxy acetone phosphate (DHAP), which was then further 
processed in the same reaction vessel by the addition of 
fructose-1,6-diphosphate aldolase in the presence of several 
aldehyde substrates to produce a variety of unusual 
branched-chain sugars (ketose-l-phosphates, Fig. Zb), a 
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Multienzyme synthesis of carbohydrates. A  
star indicates enzymes produced by genetic 
engineering. (a) Synthesis of ribose and 
ribulose-1,6-diphosphate with hexokinase, 
glucose-6-phosphate dehydrogenase, 
6-phosphogluconate dehydrogenase, 
phosphoribose isomerase and 
phosphoribulokinase. (b) The multienzyme 
one-flask synthesis of ketose-1 -phosphates 
with invertase, xylose isomerase, hexokinase, 
glucose-g-phosphate isomerase, fructose- 
g-phosphate kinase*, fructose-l ,6- 
biphosphate aldolase and triose-phosphate 
isomerase. (c) Synthesis of dTDP-L- 
rhamnose from dTDP-b-glucose with 
dTDP-o-glucose-4,6-dehydratase’, 
dTDP-4-keto-rhamnose-3,5-epimerase* and 
dTDP-6-deoxy-L-/yxo-hexulose-4-reductase’. 
Synthesis of abequose from CDP-D-glucose 
with CDP-glucose-4,5-dehydratase*, CDP-6- 
deoxy-o;uylo-4-hexulose-3-dehydrase’, 
CDP-6-deoxy-A3,4-glucoseen reductase’ 
and CDP-3,6-dideoxy-o-xy/o-4-hexulose-4- 
reductase*. (d) Synthesis of (6/?)- and 
(6S)-fluoroshikimic acids from erythrose-4- 
phosphate and 3-fluorophosphoenol pyruvate 
with DHAP synthase’, dehydroquinate 
synthase, dehydroquinase and shikimate 
dehydrogenase. (e) Synthesis of sialyl-Lewisx 
from GlcNAcf3Oallyl with 3-l ,4-galactosyl- 
transferase, o-2,3sialyltransferase* and 
a-1,3-fucosyltransferase’. (f) Synthesis of sialyl 
T-antigen from N-acetylgalactosamine with 
f3-galactosidase and a-2,3sialyltransferase*. 
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process which Fessner and Walter [S] termed ‘artificial 
metabolism’ as the routes evolved are not those of the 
normal glycolytic pathway. The yields were increased by 
replacing the rate-limiting enzyme with a recombinant 
isozyme with more favorable kinetics. Another synthesis 
(Fig. Zc) involves the monosaccharides found in the O-anti- 
genie polysaccharide chains of Suhonda enterica (which 
may be used in vaccine production). Both rhamnose and 
abequose have been produced using cell-free extracts of 
Escherich coli strains expressing the S. enterica rbf genes 
[6,7]. In another example, Duggan et al. [8] supplied eryth- 
rose-4-phosphate and the unnatural substrate 3-fluoro 
phosphoenolpyruvate to enzymes of the shikimate biosyn- 
thetic pathway to produce equal amounts of the ‘unnatural’ 
(R)- and (S)-6-fluoro analogs of shikimic acid (Fig. Zd), 
potentially useful as antibiotics. 
Cell-surface oligosaccharides are highly diversified in struc- 
ture and are important as antigenic determinants and for 
many cell functions such as receptor binding. Recent devel- 
opments pioneered by C-H. Wong have resulted in the 
multienzyme synthesis of several of these complex 
oligosaccharides. Representative of Wong’s work is the syn- 
thesis of the tetrasaccharide sialyl LewisX (Fig. Ze), a candi- 
date for the treatment of reperfusion tissue injury, which 
can now be produced on the kilogram scale using recombi- 
nant enzymes and sugar nucleotide regeneration [9]. Along 
the same lines, Kren and Thiem [lo] have described the 
single-pot preparation of the sialylated trisaccharide epitope 
of the T-antigen (Fig. Zf), which is expressed on the surface 
of several cell types, including epithelial cancer cells, and is 
thus important in immunological studies and for the synthe- 
sis of antitumor vaccines. In all of the examples above, 
important cofactors were regenerated with enzymatic 
systems at the steps (shown in Fig. 2) requiring cofactors. 
Enzymatic synthesis of bacterial polyketides 
The polyketide family of natural products includes a 
number of important antibiotics, and their modular nature 
makes them particularly amenable to in vitro biosynthesis. 
Complex polyketides are assembled by a process akin to 
the synthesis of fatty acids, using acetyl-, propionyl- and 
butyryl-CoA as starter units, which are attached to large, 
multifunctional polyketide synthases (PKSs) by a thioester 
linkage. The elongation process involves a decarboxylative 
condensation usually with malonyl- or methylmalonyl- 
CoA. After each condensation, the growing polyketide 
chain can be tailored by reductive and subsequent dehy- 
drative processes. Finally, the thioester is hydrolyzed and 
the released polyketide cyclized either by macro-lactone 
formation or by aldol/Claisen chemistry to yield an aro- 
matic polyketide. These pathways have been analyzed by 
introducing genes for the PKSs and the subsequent reduc- 
tion and cyclization steps into Streptomyces spp. There are 
two notable examples that represent a combination of 
whole-organism engineering and in vitro synthesis. In the 
first, Shen and Hutchinson [ll] constructed a strain of 
Streptomyces glaucescens that overexpressed the tetraceno- 
mycin TcmK,L,M and N genes. A cell-free lysate derived 
from this strain produced tetracenomycin F2 (Tcm FZ) 
from acetyl CoA and malonyl CoA (Fig. 3a). Addition of 
TcmJ to the other four genes greatly increased the yield of 
Tcm FZ in vitro. Tcm Fl was synthesized after addition of 
the purified Tcm FZ cyclase to the cell-free five-enzyme 
system, and addition of the necessary oxidase completed 
the system to yield Tcm D3 (Fig. 3a). This work represents 
the first example of in vitro multienzyme synthesis of 
aromatic polyketides. 
In the second example [lZ], a strain of Sacchzropolyspora 
erythraea was engineered to contain an altered 6-deoxy- 
erythronolide B synthase (DEBS) gene resulting in the in 
vitro production of novel triketide lactones. DEBS, which 
synthesizes the aglycone core of erythromycin A, contains 
30 active sites distributed among three large multi- 
enzymes, DEBS 1, DEBS 2 and DEBS 3 (molecular mass 
-300 kDa each). The study of one of these domains in 
vitro was made possible by the relocation of the 
thioesterase/cyclase (TE, responsible for release and/or 
cyclization of the polyketide chain) from the end of the 
third multienzyme, DEBS 3, to the carboxy terminus of 
DEBS 1 (Fig. 3b). In a cell-free lysate derived from this 
strain, the lactone 1B (Fig. 3b) was synthesized from pro- 
pionyl CoA and methylmalonyl CoA. This represents the 
activity of the first part of the elongation process, which 
stops halfway because of the absence of DEBS 2 and 3. 
This elegant piece of engineering allowed the first cell- 
free synthesis of a lactonic triketide, a compound not nor- 
mally found in cultures that produce erythromycin (a 
heptaketide). It was also found that there is a relaxed 
specificity for the starter unit; the system can tolerate 
acetyl-, propionyl-, and n-butyryl-CoA as substrates result- 
ing in structures lA, 1C and lD, respectively (Fig. 3). 
Porphyrins and corrins 
Another excellent example of how reconstitution of a multi- 
enzyme system has been exploited in the analysis of a 
complex pathway is illustrated by the system developed 
for the analysis of porphyrin and corrin synthesis (Fig. 4), 
in which of all of the in vitro variations outlined in Fig. 1 
are represented. Genes from three different organisms 
were overexpressed; hem genes and CJSG from E. co/i, cbi 
genes from Salmonella ~phmukun LT2, and cob genes 
from a strain of Pseudomonas denitrificans that is used for 
the commercial production of vitamin B,,. Overproduc- 
tion of the enzymes allowed functional and mechanistic 
studies on some of them [13-191 and immobilization of 
the first three enzymes of the pathway (Fig. 4, steps l-3) 
allowed the design of a reusable system for the production 
of uro’gen III from &aminolevulinic acid (ALA) on the 
100 mg scale in 83 % yield [ZO]. By limiting the reaction to 
only those enzymes required for the synthesis of a given 
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Polyketide biosynthesis. (a) The biosynthetic 
pathway from acetyl CoA and malonyl CoA to 
tetracenomycin in Streptomyces glaucescens 
showing steps catalyzed in vitro by 
TcmJKLMN, Tcm F2 cyclase and Tcm Fl 
monooxygenase to form Tcm D3. (b) Triketide 
lactones can be synthesized in vitro by an 
engineered triketide lactone synthase 
(DEBSl -TE). This includes an acyl carrier 
protein (ACP) domain (to which the growing 
polyketide is attached) and acyl transferase 
(AT), p-ketoacyl ACP synthase (KS) and 
6-ketoacyl reductases (KR) domains that 
synthesize the polyketide in a stepwise 
manner. The terminal thioesteraselcyclase 
(TE) domain releases the product from the 
synthase with cyclization. The different 
products, 1 A-lD, are produced by varying 
the starting substrate. 
intermediate, precorrin-2, precorrin3, precorrin-3x, pre- 
corrin-4 and precorrin-5 were synthesized and r3C-labeled, 
and their structures fully characterized by NMR [Zl-241. 
Several new ‘unnatural’ products were synthesized, for 
example, trimethylpyrrocorphin, the result of mismethyla- 
tion (at C-12) of precorrin-2 by CysG [ZZ], and compound 
4x, resulting from mismethylation (at C-l 1) of precorrin 3 
by the methylase encoded by c&F [ZS]. These reactions 
were prevented in the synthesis of later intermediates by 
replacing CysG and CbiF with the homologous enzymes, 
CobA and CobM, which do not display the abnormal 
methylation properties. The synthesis of compound 4x led 
to the identification of the enzyme (encoded by c&F or 
co&‘) responsible for addition of the methyl group at C-l 1 
of precorrin4 to form precorrin5 (step 8). The power of 
this multienzyme system was further demonstrated by 
the discovery that CobG (step 6) requires 0, [26], an 
unexpected cofactor since many of the intermediates are 
sensitive to oxidation (Fig. 4). 
The longest synthetic pathway successfully assembled in a 
single ex vko reaction so far is our own reconstruction of 
the pathway yielding the corrin hydrogenobyrinic acid 
from the starting substrates ALA and SAM (reactions 
l-12) using all 12 of the required enzymes that had been 
produced in E. co/i by genetic engineering [27,28]. The 
overall yield (based on ALA) was 20 %, reflecting an 
average of at least 90 % conversion at each of 17 individual 
steps. Most crucial to a good yield was a high level of 
uro’gen III synthase activity to prevent the chemical for- 
mation of uro’gen I, and an excess of uro’gen III methyl- 
transferase to prevent decarboxylation of uro’gen III (the 
first step of the heme pathway) by endogenous decarboxy- 
lase (encoded by the hemE gene). Thus a high yield of 
hydrogenobyrinic acid was made possible by supplying an 
excess of each desired enzyme obtained through genetic 
engineering to efficiently shunt each intermediate down 
the desired pathway and away from competing pathways. 
As the steps leading from hydrogenobyrinic acid to vitamin 
B,, (the chemical insertion of cobalt into hydrogenobyrinic 
acid to afford cobyrinic acid and the self assembly of the 
nucleotide loop (Fig. 4, steps 13-16)) have previously been 
demonstrated [29], the in oh-o chemo-enzymatic synthesis 
of vitamin B,, is now complete. 
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Figure 4 
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The biosynthetic pathway from &aminolevulinic acid (ALA) to 
hydrogenobyrinic acid. The enzyme catalyzing each reaction and its 
corresponding gene are: (1) ALA dehydratase (hem@, (2) 
porphobilinogen (PBG) deaminase (hemC), (3) uroporphyringen Ill 
(uro’gen Ill) synthase (hemD), (4) uro’gen Ill methyltransferase (cysG, 
cob/l), (5) precorrin 2 methyltransferase (cob/J, (6) precorrin-3 oxidase 
(cobG), (7) precorrin-3 hydroxylactone methyltransferase (ring 
contraction; cobJ, (8) precorrin-4 methyltransferase (cobM, cbifl, (9) 
precorrin-5 methyltransferase (loss of acetic acid; cobn, (10) 
precorrin6x reductase (cobK), (11) precorrin6y decarboxylase and 
methyltransferase (cobL), (12) precorrin-8 methylmutase (cobHI, 
(13) cobalt insertion, (14) esterification, (15) addition of nucteotide 
loop, (16) ammonolysis. Alternative pathways and observed derailment 
products are indicated in boxes. 
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In syntheses, such as the one described above, that 
require SAM as a methyl donor, enzymatic generation of 
SAM is desirable. Several problems have been encoun- 
tered in attempts to synthesize SAM enzymatically, 
including product inhibition of the only enzyme available 
in large amounts, recombinant E. co/i SAM synthetase. 
This problem limited accumulation of SAM to less than 
1.0 mM, but has been overcome by production in E. cob’ 
of the homologous SAM synthetase (encoded by the 
SAM2 gene) of Saccharomyces cewvisiae, which is not 
limited by product inhibition. The utility of this enzyme 
has been demonstrated by the successful supply of SAM 
in sitzc from ATP and methionine in the multienzyme syn- 
thesis of precorrin-2 (J. Park, J. Tai, C.A.R. and A.I.S., 
unpublished results). 
Prognosis 
It is now evident that the multienzyme synthesis of 
natural products has, within the last decade, passed from 
feasibility to practical reality [30,31]. The main problems 
still to be addressed include the development of rapid 
techniques for screening cDNA libraries to allow facile 
heterologous expression of plant enzymes, and the inclu- 
sion of a wider variety of enzyme activities (such as cyto- 
chrome P-4505 and non-heme iron enzymes catalyzing 
hydroxylation) and reaction pathways involving coenzymes 
such as B,, and pyridoxal phosphate. 
It now seems certain (although this could not have been 
foreseen) that there is virtually no limit to the number of 
enzymes that can be combined in a single reactor to 
produce a complex structure in good yield. What is truly 
remarkable is the lack of product/substrate inhibition, which 
is probably due to the irreversible nature of many of the 
later steps in a given sequence. It is our hope that the field 
will expand into the synthesis of natural products that are 
currently inaccessible by conventional chemical synthesis. 
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